Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

CHE stock hub

Chemed Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CHEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.6B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

CHE

In the news

Latest news · CHE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17

P25 12.3P50 18.4P75 33.1

Trailing P/E23.2

P25 14.9P50 23.2P75 38.5

ROE25.6

P25 -105.6P50 -46.5P75 -3.1

ROIC23.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CHE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

271

Groups with data

Currency

USD

Showing 271 of 271 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000019584
Company name	Chemed Corporation
Country	United States
Country code	US
Cusip	16359R103
Employees	15,811
Employees Change	116%
Employees Change Percent	0.74
Enterprise value	$5.8B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
Isin	US16359R1032
Last refreshed	2026-05-10
Market cap	$5.6B
Market cap category	Mid-Cap
Price	$424
Price currency	USD
Rev Per Employee	160,682.31x
Sector	Healthcare
Sic	8082
Symbol	CHE
Website	https://www.chemed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.63%
EV Earnings	22.44x
EV Sales Forward	2.12x
EV/EBIT	17.47x
EV/EBITDA	14.75x
EV/FCF	15.46x
EV/Sales	2.29x
FCF yield	6.72%
Forward P/E	17.04x
P/B ratio	6.61x
P/E ratio	23.18x
P/S ratio	2.21x
PE Ratio10 Y	28.64x
PE Ratio3 Y	28.09x
PE Ratio5 Y	27.9x
PEG ratio	1.42x
PS Forward	2.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.13%
EBITDA Margin	15.55%
FCF margin	14.84%
Gross margin	32.38%
Gross Profit	$822.5M
Gross Profit Growth	-5.09%
Gross Profit Growth Q	-0.3%
Gross Profit Growth3 Y	2.65%
Gross Profit Growth5 Y	2.58%
Net Income	$259.8M
Net Income Growth	-15.86%
Net Income Growth Q	-7.6%
Net Income Growth Years	0%
Net Income Growth3 Y	2.74%
Net Income Growth5 Y	-4.61%
Pretax Margin	13.73%
Profit Margin	10.23%
Profit Per Employee	$16,431
Profitable Years	22
ROA	12.79
Roa5y	14.44
ROCE	27.48
ROE	25.6
Roe5y	30.27
ROIC	23.47
Roic5y	27.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.04%
Cagr15y	13.28%
Cagr1y	-26.18%
Cagr20y	11.28%
Cagr3y	-7.98%
Cagr5y	-2.48%
Div CAGR10	9.36%
Div CAGR3	15.31%
Div CAGR5	11.41%
EPS Growth	-10.85
EPS Growth Q	-0.41
EPS Growth Years	0
EPS Growth3 Y	4.82
EPS Growth5 Y	-1.89
FCF Growth	19.7%
FCF Growth Q	265.31%
FCF Growth3 Y	22.02%
FCF Growth5 Y	-3.47%
OCF Growth	21.34%
OCF Growth Q	169.42%
OCF Growth10 Y	10.31%
OCF Growth3 Y	18.12%
OCF Growth5 Y	-2.62%
Revenue Growth	2.07x
Revenue Growth Q	1.63x
Revenue Growth Quarters	1x
Revenue Growth Years	3x
Revenue Growth3 Y	5.48x
Revenue Growth5 Y	3.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.56
Assets	$1.5B
Cash	$16.9M
Current Assets	$274.1M
Current Liabilities	$321.4M
Debt	$236.9M
Debt EBITDA	$0.51
Debt Equity	$0.28
Debt FCF	$0.63
Equity	$848M
Interest Coverage	172.6
Liabilities	$687.8M
Long Term Assets	$1.3B
Long Term Liabilities	$366.4M
Net Cash	$-220.1M
Net Cash By Market Cap	$-3.92
Net Debt EBITDA	$0.56
Net Debt Equity	$0.26
Net Debt FCF	$0.58
Tangible Book Value	$80.1M
Tangible Book Value Per Share	$6.06
WACC	6.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.85
Inventory Turnover	229.1
Net Working Capital	$-22.9M
Quick ratio	0.72
Working Capital	$-47.4M
Working Capital Turnover	$30.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.66%
Dividend Growth	21.05%
Dividend Growth Years	17%
Dividend per share	$2.4
Dividend Years	56
Dividend Yield	0.57%
Ex Div Date	2026-02-23
Last Dividend	$0.6
Payout Frequency	Quarterly
Payout Ratio	12.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	240.58%
1Y total return	-26.17%
200-day SMA	431.8
3Y total return	-22.1%
50-day SMA	396.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-11.78%
All Time High	654.6
All Time High Change	-35.19%
All Time High Date	2024-03-15
All Time Low	1.5
All Time Low Change	28,184%
All Time Low Date	1974-09-30
ATR	12.06
Beta	0.54
Beta1y	0.52
Beta2y	0.3
Ch YTD	-0.84
High	426.2
High52	584
High52 Date	2025-05-20
High52ch	-27.35%
Low	418.2
Low52	365.2
Low52 Date	2026-03-27
Low52ch	16.17%
Ma50ch	6.88%
Price vs 200-day SMA	-1.75%
RSI	63.78
RSI Monthly	41.4
RSI Weekly	49.05
Sharpe ratio	-0.87x
Sortino ratio	-0.91
Total Return	6.22%
Tr YTD	-0.72
Tr15y	548.81%
Tr1m	9.08%
Tr1w	0.5%
Tr3m	-5.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Ratings	Buy
Earnings EPS Estimate	$5.21
Earnings EPS Estimate Growth	-7.46
Earnings Revenue Estimate	648,038,120x
Earnings Revenue Estimate Growth	0.17x
Operating Income	$333.7M
Operating Income Growth	-14.29
Operating Income Growth Q	-10.74
Operating Income Growth3 Y	0.31
Operating Income Growth5 Y	1.12
Operating margin	13.13
Price target	$502
Price Target Change	$18.21

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,992,879%
Float Percent	98.29%
Net Borrowing	101,239,000
Shares Insiders	1.61%
Shares Institutions	103.82%
Shares Out	13,219,352
Shares Qo Q	-2.28%
Shares Yo Y	-5.66%
Short Float	3.31%
Short Ratio	1.6
Short Shares	3.26

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$339.3M
Average Volume	267,849.25x
Bv Per Share	64.15
CAPEX	$-66.6M
Ch10y	227.6
Ch15y	495.6
Ch1m	9.08
Ch1w	0.5
Ch1y	-26.53
Ch20y	651.7
Ch3m	-5.24
Ch3y	-22.96
Ch5y	-13.27
Ch6m	-2.38
Change	-0.37%
Change From Open	-0.46
Close	425.8
Days Gap	0.1
Depreciation Amortization	61,397,000
Dollar Volume	64,662,315.1
Earnings Date	2026-04-23
Earnings Time	amc
EBIT	$333.7M
EBITDA	$395.1M
EPS	$18.3
F Score	5
FCF	$377.1M
FCF EV Yield	6.47x
FCF Per Share	$28.53
Financing CF	-517,318,000
Fiscal Year End	December
Founded	1,970
Goodwill	687,501,000
Graham Number	162.52002
Graham Upside	-61.69
Income Tax	$89.2M
Investing CF	-83,455,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Date	2005-05-12
Last Split Type	Forward
Last10k Filing Date	2026-02-27
Lynch Fair Value	$91.5
Lynch Upside	-78.43
Ma150	426
Ma150ch	-0.41%
Ma20	404.4
Ma20ch	4.9%
Net CF	-157,026,000
Next Earnings Date	2026-07-28
Open	426.2
Optionable	Yes
P FCF Ratio	14.87
P OCF Ratio	12.64
Payment Date	2026-03-13
Position In Range	75.5
Ppne	341,331,000
Price Date	2026-05-08
Price EBITDA	$14.2
Ptbv Ratio	70.04
Relative Volume	0.58x
Revenue	2,540,548,000x
SBC By Revenue	1.49x
Share Based Comp	37,804,000
Tax By Revenue	3.51x
Tax Rate	25.55%
Tr20y	747.22%
Tr6m	-2.12%
Us State	Ohio
Volume	152,412
Z Score	10.99

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

CHE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$2.40 annual per share

Payout ratio

+12.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.4%

17 consecutive years of growth

Total shareholder yield

+6.2%

Next ex-dividend date: 2026-02-23

Performance

CHE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CHE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+103.8%

Float: +98.3% of shares outstanding

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CHE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.8

Neutral momentum band

Price vs 200-day MA

-1.7%

50/200-day relationship not available

Beta (5Y)

0.54

Less volatile than the market

Sharpe ratio

-0.87

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CHE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CHE stock rating?

Chemed Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CHE analysis?

The full report lives at /stocks/CHE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CHE?

The latest report frames CHE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CHE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.